title: Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait.
abstract: The protective effect of the lyophilised SAG2 oral vaccine bait DBL2, already demonstrated on laboratory dogs, needed to be verified on common Tunisian dogs. Seven Tunisian dogs consumed totally or partially one DBL2 bait containing 10(8.3) TCID50 of the highly attenuated rabies vaccine strain, SAG2. Five of the seven vaccinated animals survived a challenge administered 33 days later with a Tunisian canine street rabies virus to which five of the six controls that were not vaccinated and had no specific antibodies succumbed. The partial or total consumption of a single DBL2 bait thus conferred a protective immune response similar to that observed in laboratory dogs to dogs of poor health status. The sero-antibody response was, however, weak: only two vaccinated dogs exhibited a significant neutralising antibody response after vaccination and before the challenge, and four after the challenge.
authors.affiliation: Institut de la recherche vétérinaire de Tunisie, Tunis, Tunisia.
authors.forename: S
authors.initials: S
authors.lastname: Hammami
authors.forename: C
authors.initials: C
authors.lastname: Schumacher
authors.forename: F
authors.initials: F
authors.lastname: Cliquet
authors.forename: A
authors.initials: A
authors.lastname: Tlatli
authors.forename: A
authors.initials: A
authors.lastname: Aubert
authors.forename: M
authors.initials: M
authors.lastname: Aubert
mesh_terms: D000284:Administration, Oral; D000818:Animals; D004283:Dog Diseases / Q000517:prevention & control*; D004285:Dogs; D005260:Female; D005612:Freeze Drying; D008297:Male; D011818:Rabies / Q000517:prevention & control* / Q000662:veterinary*; D011819:Rabies Vaccines / Q000008:administration & dosage; D014416:Tunisia; D014611:Vaccination / Q000662:veterinary*; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014614:Vaccines, Synthetic / Q000008:administration & dosage
chemical_list: D011819:Rabies Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic